Page last updated: 2024-08-23

etoposide and Leukopenia

etoposide has been researched along with Leukopenia in 212 studies

Research

Studies (212)

TimeframeStudies, this research(%)All Research%
pre-199055 (25.94)18.7374
1990's104 (49.06)18.2507
2000's36 (16.98)29.6817
2010's15 (7.08)24.3611
2020's2 (0.94)2.80

Authors

AuthorsStudies
Ino, K; Kajiyama, H; Kikkawa, F; Kotani, T; Niimi, K; Nishino, K; Sato, S; Suzuki, S; Yamamoto, E1
Bao, Y; Chen, M; Chen, MY; Chen, PC; Chen, QX; Dong, BQ; Fan, Y; Fang, M; Guo, Y; Hong, W; Hu, X; Jiang, YH; Jin, Y; Kong, Y; Liu, JS; Ma, HL; Mao, WM; Peng, F; Song, ZB; Sun, WY; Tang, HR; Wang, J; Xu, XL; Xu, YJ; Yu, C; Yu, XM; Zhang, L; Zhang, YP; Zhao, Q; Zhou, XM; Zhu, HN; Zhu, L1
Han, D; Li, S; Ren, X; Shang, W; Sun, L; Wang, G; Xu, L1
Bison, B; Bojko, S; Gielen, GH; Hoffmann, M; Kortmann, RD; Kramm, CM; Pietsch, T; Seidel, C; von Bueren, AO; Warmuth-Metz, M1
Engel, C; Loeffler, M; Loibl, S; Schirm, S; Scholz, M1
Fukui, T; Igawa, S; Katagiri, M; Kubota, M; Kurahayashi, S; Mitsufuji, H; Naoki, K; Nishinarita, N; Okuma, Y; Ono, T; Ozawa, T; Sasaki, J; Shirasawa, M; Sone, H; Sugimoto, A; Sugita, K1
Allan, E; Ayan, A; Barney, CL; Bazan, JG; DiCostanzo, D; Grecula, J; Haglund, KE; Otterson, GA; Scoville, N; Williams, T; Xu-Welliver, M1
Gálvez, A; Hancock, CL1
Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y1
Cheng, Y; Cui, HX; Li, ZL; Ma, LX; Sun, SY; Yang, CL1
Bao, Y; Chen, M; Chen, YY; Gao, JM; He, H; Hu, X; Liu, Y; Poudel, S; Sun, ZW; Wang, WH; Wang, Y; Zhang, L; Zhuang, TT1
Cui, XZ; Hao, XS; Li, LF; Li, W; Liu, PF; Liu, XM; Qiu, LH; Wang, HQ; Zhang, HL1
Bono, K; Fujita, Y; Ito, S; Kawabata, A; Kawaishi, M; Kuwano, K; Mikami, J; Numata, T; Tamura, K; Wakui, H; Yumino, Y1
Clarke, SJ; Cunningham, D; Dent, O; Robertson, G; Sharma, R; Smith, P1
Lou, F; Pan, HM; Zhu, YH1
Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L1
Fujii, M; Ito, M; Momota, H; Motomura, K; Natsume, A; Wakabayashi, T1
Agatsuma, T; Hanaoka, M; Ito, M; Kanda, S; Koizumi, T; Kubo, K; Urushihata, K; Yamamoto, H1
Chen, Q; Huang, JZ; Liang, JG; Lin, D; Shi, CM; Zhong, DT1
Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M1
Fu, K; Hao, XS; Hou, Y; Li, LF; Li, W; Liu, XM; Qian, ZZ; Qiu, LH; Wang, HQ; Zhang, HL; Zhou, SY1
Fueki-Yoshioka, H; Hama-Yamamoto, K; Hino, R; Hiromasa, K; Izu, K; Kabashima-Kubo, R; Kobayashi, M; Nakamura, M; Ohmori, S; Okura, R; Sawada, Y; Shimauchi, T; Sugita, K; Tajiri, M; Tokura, Y; Yamada, S; Yamaguchi, T; Yoshiki, R; Yoshioka, M; Yoshizawa, M1
Li, AW; Liu, JM; Luo, J; Wu, FY; Zheng, D1
Fujii, M; Kanamori, N; Kasakura, Y; Kochi, M; Mochizuki, F; Takayama, T; Wakabayashi, K; Yamagata, M1
Ardizzoni, A; Biesma, B; Buchholz, E; Burghouts, J; Debruyne, C; Dziadziuszko, R; Gans, S; Giaccone, G; Karnicka-Mlodkowska, H; Legrand, C; Manegold, C; Postmus, PE; Tjan-Heijnen, VC; Van Meerbeeck, JP1
Ardizzoni, A; Biesma, B; Buccholz, E; Burghouts, JT; Caleo, S; Crott, R; Debruyne, C; Giaccone, G; Gorlia, T; Manegold, C; Postmus, PE; Tjan-Heijnen, VC1
Eguchi, K; Goto, K; Hojo, F; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsumoto, T; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Tamura, T; Yoshimura, K1
Boissevain, F; Bredenfeld, H; Diehl, V; Eich, H; Engert, A; Franklin, J; Josting, A; Koch, P; Koch, T; Müller-Hermelink, HK; Naumann, R; Paulus, U; Reineke, T; Rueffer, U; Sieber, M; Soekler, M; Wolf, J; Worst, P1
Beganovic, S; Niell, HB; Richey, S; Wan, JY1
Cardarelli, N; Carle, F; Cellerino, R; Cetto, GL; Contu, A; D'Aprile, M; Fedeli, SL; Fiorentini, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Parziale, AP; Piga, A1
Abdel-Rahman, S; Fahn, W; Fiegl, M; Issels, RD; Schlemmer, M; Wendtner, CM1
Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S1
Adachi, M; Horichi, N; Ichikawa, I; Imai, T; Kashiwabara, Y; Kiuchi, Y; Kogo, M; Koichi, K; Murayama, J; Saito, Y1
Hondoh, H; Morii, K; Onda, K; Shinbo, Y; Takahashi, H; Takeuchi, S; Tamura, T; Tanaka, R; Yamanaka, R1
Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J1
Sun, ZJ; Wan, XR; Xiang, Y; Yang, XY1
Hofland, KF; Jensen, PB; Sehested, M; Thougaard, AV1
Fan, Y; Huang, ZY; Luo, LH; Yu, HF1
Engel, C; Loeffler, M; Scholz, M1
Chen, LK; Liang, Y; Xu, GC; Yang, QY; Zhang, LN1
Akaza, H; Ando, S; Hinotsu, S; Kawai, K; Miyanaga, N; Oikawa, T; Sekido, N; Shimazui, T1
Azuma, K; Hashine, K; Karashima, T; Kasahara, K; Miura, N; Nakatsuzi, H; Numata, K; Sumiyoshi, Y1
Aydiner, A; Camlica, H; Derin, D; Guney, N; Tas, F; Topuz, E1
Jiang, J; Kong, BH; Nan, FF; Wang, B; Yang, XS; Zhang, YZ1
Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G1
Huberman, MS; Lokich, JJ; Matelski, HW; Paul, S; Philips, D; Sonneborn, H; Zipoli, TE1
Aisner, J; Van Echo, DA; Whitacre, M; Wiernik, PH1
Deboer, G; Dill, J; Evans, WK; Feld, R; Osoba, D; Shepherd, FA1
Chen, TT; Costanzi, JJ; Livingston, RB; McGavran, M; Mira, JG; Samson, M1
Araya, Y; Dosaka, H; Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Onodera, S; Shimizu, T; Takaoka, K1
Bosl, GJ; Dukeman, M; Golbey, R; Herr, H; Sogani, P; Vugrin, D; Whitmore, WF; Yagoda, A1
Chahinian, AP; Green, G; Holland, JF1
Hattori, K; Ito, K; Kobayashi, S; Nakamura, S; Nakanishi, J; Ohtake, S; Yoshida, T1
Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Wesley, R; Young, RC1
Aisner, J; Konits, PH; Morris, D; Van Echo, DA; Wiernik, PH1
Demitrish, M; Duffin, H; Enochs, K; Groshko, G; Lockhard, C; Maniscalco-Greb, E; Vaughn, CB1
Barrett, A; Fitzharris, BM; Kaye, SB; McElwain, TJ; Newlands, ES; Peckham, MJ; Saverymuttu, S1
Alberto, P; Cavalli, F; Klepp, O; Renard, J; Röhrt, M1
Fukuoka, M; Hirashima, T; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Nakagawa, K; Takada, M; Tsukada, H; Yana, T1
Saeter, G; Solheim, OP; Talle, K1
Feng, FY; Shi, YK; Sun, Y1
Ben-Shahar, M; Epelbaum, R; Haim, N1
Beasley, K; Bunn, PA; Crowley, J; Gandara, DR; Hazuka, MB; Hicks, WJ; Kelly, K; Livingston, R; Upchurch, C; Weiss, GR1
Choi, CW; Choi, MS; Choi, YH; In, KH; Kang, KH; Kim, CY; Kim, JS; Nam, YJ; Shin, SW1
Barcos, M; Canellos, GP; Duggan, DB; Peterson, BA; Petroni, GR1
Greco, FA; Hainsworth, JD; Stroup, SL1
Ichikawa, G; Inuyama, Y; Kawaida, M; Kohno, N; Ohnuma, T; Shirasaka, T1
Kawakami, M; Kobayashi, S; Niwakawa, M; Ogawa, A; Okaneya, T; Tsuruta, T1
Hara, A; Niitsu, N; Shirai, T; Umeda, M1
Pfeiffer, P; Rose, C; Sørensen, P1
Karlsson, MO; Port, RE; Ratain, MJ; Sheiner, LB1
Ettinger, DS; Finkelstein, DM; Johnson, DH; Sarma, RP1
Barbhaiya, RH; Garrow, C; Greco, A; Hainsworth, JD; Igwenezue, KB; Kaul, S; Miller, AA; Schacter, LP; Srinivas, NR; Thompson, DS1
Ando, Y; Minami, H; Sakai, S; Shimokata, K1
Horiuchi, Y; Ina, K; Iwase, H; Kaneko, H; Kuroiwa, A; Kusugami, K; Morise, K; Oka, Y; Shinoda, M; Suga, S1
Shi, YK; Su, M; Sun, Y1
Shi, TZ; Yan, JL1
Ashihara, E; Fujita, N; Goto, H; Hirata, T; Inaba, T; Nakagawa, M; Okawa, K; Oku, N; Shimazaki, C; Yamagata, N1
Edison, M; Gazdar, AF; Ihde, DC; Kramer, BS; Lesar, M; Linnoila, RI; Mulshine, JL; Phares, JC; Phelps, RM; Steinberg, SM1
Horikawa, S; Katagami, N; Kobayashi, H; Maekawa, N; Matsumoto, H; Matsunaga, K; Nishiyama, H; Okazaki, M; Sugita, T; Suzuki, Y1
Calame, W; Douwes-Idema, AE; Mattie, H; van den Barselaar, MT; van Furth, R1
Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M1
Caglar, M; Ersoy, F; Gunay, M; Gurgey, A; Kale, G; Kucukali, T; Sayli, T1
Egami, K; Furusawa, S; Mikuni, C; Mori, M; Nomura, T; Shimoyama, M; Sugimoto, T; Suzuki, K; Takagi, T; Yoshida, T1
de Wit, R; Logmans, A; Stoter, G; van den Gaast, A; van der Burg, ME; Verweij, J1
Ariyoshi, Y; Fukuoka, M; Furuse, K; Hayashihara, K; Komatsu, H; Nagao, K; Nakajima, H; Noda, K; Tanaka, K; Terashima, Y1
Bruun, B; Daugaard, G; Geertsen, P; Hansen, F; Nielsen, H; Schønheyder, H1
Davidson, A; Lewis, I; Pearson, AD; Pinkerton, CR; Stevens, MC1
Ettinger, DS; Gradishar, W; Johnson, DH; Larson, MM; Merkel, D; Schiller, JH1
Miller, AA; Tolley, EA1
Achterrath, W; Berger, M; Berns, T; Fink, U; Harstrick, A; Knipp, H; Meyer, HJ; Preusser, P; Stahl, M; Wilke, H1
Ashley, S; Holborn, J; Jones, AL; Smith, IE1
Ardizzoni, A; Bracarda, S; Bruzzi, P; Crinò, L; Garrone, O; Mariani, GL; Pennucci, MC; Rosso, R; Sertoli, MR; Venturini, M1
Griffin, JP; Mauer, AM; Miller, AA; Niell, HB; Tolley, EA1
Baker, LH; Zalupski, MM1
Fukuda, H; Hosokawa, K; Kondo, H; Ohtsu, A; Saito, D; Shimada, Y; Shirao, K; Yamao, T; Yoshida, S1
Akiyama, H; Kanda, Y; Onozawa, Y; Sakamaki, H; Sasaki, T; Takamoto, S; Tanikawa, S1
Creagan, ET; Eagan, RT; Foote, RL; Frytak, S; Jett, JR; Richardson, RL; Shaw, EG; Su, JQ1
Fleming, GF; Gray-Stern, W; Lestingi, TM; Mick, R; Ratain, MJ; Schilsky, RL; Vokes, EE1
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L1
Canpynar, H; Cetin, M; Hiçsönmez, G; Kansu, E; Tuncer, AM1
Ando, M; Ando, Y; Minami, H; Saka, H; Sakai, S; Shimokata, K1
Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T1
Blessing, JA; Creasman, WT; Lewandowski, GS; Rose, PG; Webster, KD1
Masaoka, T1
Ando, Y; Minami, H; Ratain, MJ; Shimokata, K1
Falkson, CI; Nel, JS1
Akbulut, H; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoguz, H1
Chen, YM; Chou, CM; Lin, WC; Liu, JM; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, MF; Yang, KY1
Chen, YM; Lin, WC; Ming-Liu, J; Perng, RP; Tsai, CM; Whang-Peng, J; Yang, KY1
Niitsu, N; Umeda, M1
Camoriano, JK; Fitch, TR; Frytak, S; Rajkumar, SV; Rubin, J1
Beck, D; Béhar, C; Bergeron, C; Bernard, JL; Bordigoni, P; Coze, C; Dusol, F; Frappaz, D; Hartmann, O; Leverger, G; Mechinaud, F; Michon, J; Otten, J; Philip, T; Plantaz, D; Plouvier, E; Rubie, H; Zucker, JM1
Gray, JR; Greco, FA; Hainsworth, JD; Hopkins, LG; Kalman, LA; Patten, JE; Stroup, SL; Thomas, M1
Anderson, S; Dunlop, DJ; Eatock, MM; Fitzsimmons, EJ; Lucie, N; Paul, J; Reed, NS; Soukop, M; Steward, WP; Tansey, P1
Ansari, R; Blanke, C; Carey, MA; Einhorn, L; Fisher, B; Monaco, F; Nichols, C; Sandler, A; Spiridonidis, CH1
Badzio, A; Jassem, J; Jereczek-Fossa, B; Karnicka-Młodkowska, H; Kowal, E; Krawczyk, K; Malak, K; Moś-Antkowaik, R; Pilarska-Machowicz, A; Radzikowska, E1
Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Liu, JH; Tung, SL; Wang, WS; Yen, CC1
Chao, Y; Chen, LT; Chen, YM; Chiou, TC; Hsieh, RK; Liu, JM; Liu, SM; Tiu, CM; Whang-Peng, J; Wu, HW1
Goya, T; Koshiishi, Y; Miya, T; Nogami, H; Sasaki, Y; Yanagida, O1
Abe, S; Hayashi, I; Kawakami, Y; Kurita, Y; Matsuda, T; Nakabayashi, T; Nishiwaki, Y; Saijo, N; Suzuki, S; Takahashi, T; Tamura, T; Yamamoto, N1
Barbhaiya, RH; Fields, SZ; Himpler, BS; Igwemezie, LN; Kaul, S; Litam, PP; McAleer, C; Schacter, LP; Schilder, RJ; Wright, J1
Angeli, A; Berruti, A; Dogliotti, L; Pia, A; Terzolo, M1
Fujii, H; Igarashi, T; Itoh, K; Minami, H; Ohtsu, T; Saijo, N; Sasaki, Y1
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T1
Asamoto, H; Furuse, K; Iwami, F; Kawahara, M; Kuba, M; Saijo, N; Shimoyama, M; Tamura, T1
Bennett, JM; Lee, S; Paietta, E; Rowe, JM; Sikic, BI; Tallman, MS; Wiernik, PH1
Ambrosch, G; Huber, H; Mohn-Staudner, A; Oberaigner, W; Oroszy, S; Pfeifer, W; Pirker, R; Prior, C1
Astoul, P; Boutin, C; Gouvernet, J; Irisson, M; Juin, P; Pignon, T; Ruggieri, S1
Frohmüller, H; Hofmockel, G; Langer, W; Will, R1
Barcos, M; Canellos, GP; Chung, CT; Johnson, JL; Millard, FE; Peterson, BA; Petroni, GR; Wasserman, TH1
Joseph, CD; Kuttan, G; Kuttan, R; Praveenkumar, V1
Brown, BW; Fisher, GA; Kaubisch, S; Lum, BL; Sikic, BI1
Fueki, N; Hoshino, H; Ishihara, S; Kobayashi, G; Makimoto, T; Minato, K; Mori, M; Naruse, I; Nomoto, T; Saito, R; Sato, K; Sunaga, N; Takei, Y; Takise, A; Tsuchiya, S; Watanabe, S1
Tarkowski, A; Verdrengh, M1
Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H1
Burris, HA; Erland, JB; Gray, JR; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT1
Fukuoka, M; Hirashima, T; Kobayashi, M; Masuda, N; Matsui, K; Nitta, T; Takada, Y; Yana, T1
Amon, O; Bosk, A; Handgretinger, R; Niethammer, D; Schneider, EM; Tomaske, M1
Clemm, C; Draczynski, T; Linde, K; Melchart, D; Saller, R; Wagner, H; Weber, B; Weidenhammer, W; Worku, F1
Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, F1
Bunn, PA; Ihde, DC; Radice, PA1
Jungi, WF; Mayr, AC; Schmieder, HA; Senn, HJ1
Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J1
DeVore, R; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Thomas, M; Walls, J1
Piers, DA; Postmus, PE; Smit, EF1
Helle, L; Jakobson, M; Järvinen, M; Liippo, K; Nikkanen, V; Ojala, A; Paloheimo, S; Salmi, R; Salomaa, ER; Virén, M1
Arpin, D; Bohas, C; Caillet, B; Fournel, P; Lasset, C; Pacheco, Y; Perol, M; Rebattu, P; Riou, R; Trillet-Lenoir, V1
Arnold, H; Bross, K; Heidemann, E; Heim, ME; Hoffman, I; Josten, K; Manegold, C; Reinold, HM; Schalk, KP; Steinke, B1
Hansen, HH; Hansen, M; Hansen, OP; Lund, B1
Kimura, F; Mizukami, H; Motoyoshi, K; Nagata, N; Ohtsuki, T; Takagi, S; Takemura, Y; Yamamoto, K1
Boonstra, H; Bouma, J; de Vries, EG; Mulder, NH; Sleijfer, DT; Willemse, PH1
Flaherty, L; Heilbrun, L; Kraut, M; Martino, S; Redman, B; Valdivieso, M; Wozniak, A1
O'Connor, BM; Spaulding, MB; Ziegler, P1
Airoma, G; Bianco, AR; Contegiacomo, A; De Placido, S; Ferrante, G; Gentile, M; Gridelli, C; Lauria, R; Perrone, F1
Horio, Y; Minami, H; Saka, H; Sakai, S; Shimokata, K1
Fukuoka, M; Ito, K; Kudoh, S; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N1
de Vries, EG; Gietema, JA; Mulder, NH; Oldhoff, J; Sleijfer, DT; Willemse, PH1
Anderson, N; Bern, M; Lokich, J; Moore, C1
Bitran, JD; Comis, RL; Ettinger, DS; Harris, CL; Harwood, KV; Keller, JH; Langer, CJ; Losada, M1
Asamoto, H; Fujii, H; Kawaguchi, H; Kawakami, A; Ozawa, Y; Sawano, T; Tsutsumi, T1
Achterrath, W; Eiermann, W; Hepp, H; Lenaz, L1
Bugat, R; Canal, P; Chatelut, E; Chevreau, C; de Forni, M; Houin, G; Johnson, NP; Plusquellec, Y; Roche, H1
Frazier, SR; Greco, FA; Hainsworth, JD; Johnson, DH1
Calame, W; Guiot, HF; Mattie, H1
Baker, LH; Crowley, JJ; Giri, PG; Gordon, W; Janaki, LM; Kuebler, JP; Mansouri, A; McCracken, JD; Taylor, SA; Weiss, GB1
Chasen, MR; Falkson, G; Falkson, HC1
Blancy, E; Bugat, R; Canal, P; Chatelut, E; Chevreau, C; Houin, G; Lequellec, A; Roche, H1
Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Strupp, J1
Ardizzoni, A; Baldini, E; Corcione, A; Ferrarini, M; Intra, E; Mazzanti, P; Pennucci, MC; Pistoia, V; Rosso, R; Sertoli, MR1
Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M1
Browne, MJ; Calabresi, P; Clark, JW; Cummings, FJ; Curt, G; Posner, M; Slapak, CA; Urba, S; Weitberg, A; Wiemann, M1
Gradishar, WJ; Kies, MS; Vokes, EE1
Aas, M; Fosså, SD; Hall, KS1
Caliceti, U; Guaraldi, M; Martoni, A; Occhiuzzi, L; Pannuti, F; Romagnoli, D; Rossi, AP1
Akatsuka, Y; Ando, T; Hayakawa, M; Kokubu, K; Kuwahara, Y; Morise, K; Sakai, T; Sato, Y; Tahara, H; Thin, K1
Hasegawa, K; Hino, M; Kobayashi, K; Kurane, S; Niitani, H; Tuboi, E; Yamano, Y; Yano, T1
Ouyang, PC1
Hiraki, S; Kawahara, S; Kiura, K; Moritaka, T; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yamashita, H; Yonei, T1
Bungo, M; Fujita, J; Futami, H; Hashimoto, Y; Hata, Y; Irino, S; Iuchi, Y; Kamei, M; Nakamura, H; Yamaji, Y1
Andoh, T; Hayashi, H; Kiyama, T; Miyamoto, M; Mizutani, T; Nishi, K; Nomura, T; Onda, M; Tokunaga, A; Umehara, M1
Achterrath, W; Meyer, D; Nagel, GA; Rauschning, W; Wander, HE1
Calame, W; Mattie, H; van der Waals, R; van Furth, R1
Aoyagi, H; Fujii, T; Izuo, M; Miyamoto, Y; Ohwada, S; Takeshita, M; Tanahasi, Y; Uchida, O1
Becquart, D; Klastersky, J; Libert, P; Longeval, E; Ravez, P; Rocmans, P; Sculier, JP; Thiriaux, J; van Houtte, P; Vandermoten, G1
de Vries, EG; Koops, HS; Maas, A; Mulder, NH; Mulder, PO; Sleijfer, DT; Splinter, T; van der Geest, S1
Achterrath, W; Gunzer, U; Lenaz, L; Preusser, P; Schmoll, HJ; Wilke, H1
Boossy, J; Focan, C; Schallier, D; Vandermoten, G1
Ayoub, J; Eisenhauer, E; Evans, WK; Feld, R; Hughes, P; Maroun, JA; Shepherd, FA1
Anderson, N; Bern, M; Lokich, J; Moore, C; Wallach, S; Williams, D1
Bazos, MJ; DeBoer, G; Evans, WK; Feld, R; Osoba, D; Shepherd, FA1
Anderson, PN; Baker, LH; Comis, RL; Daniels, JR; Einhorn, LH; Harvey, HA; Issell, BF; Lanzotti, VA; Lawson, RD; Wampler, GL1
Greco, FA; Grosh, WW; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN1
Barber, PV; Carroll, KB; Feinmann, D; James, RD; Lawson, BA; Steward, WP; Thatcher, N1
Kimura, K; Niitani, H1
Choo, YC; Ma, HK; Wong, LC1
Alberto, P; Cavalli, F; Joss, R; Kaplan, S; Martz, G; Mermillod, B; Obrecht, JP1
DeLeo, MJ; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Wolff, SN1
Baume, D; Droz, JP; Ghosn, M; Kramar, A; Moran, A; Ostronoff, M; Pico, JL; Salloum, E; Spielmann, M; Theodore, C1
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N; Tsubura, E1
Calciati, A; Donadio, M; Ferrati, P; Giaccone, G1
Matthias, FR; Mueller, IR; Voss, R1
Bakker, PJ; Danner, SA; Lange, JM; Veenhof, KH1
Coleman, CN; Horning, SJ; Jacobs, C; Lewis, BJ; Rosenberg, SA; Tseng, A1
Barnett, MJ; Ganesan, TS; Lister, TA; Man, T; Richards, MA; Waxman, JH; Wrigley, PF1
Dent, DM; Hayes, M; Jacobs, P; King, HS1
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S1
Hashimoto, S; Kano, A; Kawamoto, K; Konno, K; Sakata, Y; Sato, S; Takahashi, H; Wakui, A; Yokoyama, M; Yoshida, Y1
Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T1
Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Kohsaki, M; Konishi, I; Masaoka, T; Nagai, K; Shibata, H; Tsubaki, K1
Mattie, H; Meddens, MJ; Thompson, J; van Furth, R1
Felman, IE; Gala, KV; Grunberg, SM; Johnson, KB; Owens, JC1

Reviews

3 review(s) available for etoposide and Leukopenia

ArticleYear
Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis.
    European journal of cancer care, 2017, Volume: 26, Issue:6

    Topics: Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Diarrhea; Etoposide; Fatigue; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Odds Ratio; Proportional Hazards Models; Small Cell Lung Carcinoma; Thrombocytopenia; Vomiting

2017
The impact of dose per cycle of etoposide and cisplatin on outcomes in patients with extensive small-cell lung cancer.
    Clinical lung cancer, 2004, Volume: 5, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Leukopenia; Lung Neoplasms; Neoplasm Staging; Neutropenia; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytopenia; Treatment Outcome

2004
[Etoposide 21 therapy for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:14

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Palliative Care

1996

Trials

94 trial(s) available for etoposide and Leukopenia

ArticleYear
The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
    International journal of clinical oncology, 2020, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Menstrual Cycle; Methotrexate; Middle Aged; Nausea; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult

2020
Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.
    Cancer, 2020, 02-15, Volume: 126, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonia; Prospective Studies; Pulmonary Fibrosis; Radiotherapy Dosage; Research Report; Small Cell Lung Carcinoma

2020
[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult

2008
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
    BMC cancer, 2009, May-18, Volume: 9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine

2009
[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Survival Rate; Thrombocytopenia; Vomiting

2009
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine

2009
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Aug-01, Volume: 18, Issue:15

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult

2012
Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Journal of cancer research and clinical oncology, 2002, Volume: 128, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Stomach Neoplasms; Survival Rate

2002
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Oct-01, Volume: 20, Issue:19

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Europe; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Statistics, Nonparametric; Survival Rate; Treatment Outcome

2002
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cost Savings; Cost-Benefit Analysis; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Health Care Costs; Hospitalization; Humans; Incidence; Leukopenia; Lung Neoplasms; Male; Middle Aged; Placebos; Risk Factors; Survival

2003
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507.
    British journal of cancer, 2003, Mar-24, Volume: 88, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diarrhea; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival; Thrombocytopenia

2003
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone; Procarbazine; Survival; Thrombocytopenia; Treatment Outcome; Vincristine

2003
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.
    British journal of cancer, 2004, May-17, Volume: 90, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Treatment Outcome

2004
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2004, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasm Staging; Patient Selection; Salvage Therapy; Sarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome

2004
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:11

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Intravenous; Intestinal Neoplasms; Leukopenia; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Survival Rate; Treatment Outcome; Vincristine

2004
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine

2005
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine

2008
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Cancer treatment reports, 1982, Volume: 66, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine

1982
Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Random Allocation; Stomatitis; Vincristine

1984
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    American journal of clinical oncology, 1984, Volume: 7, Issue:5

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting

1984
[Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:8

    Topics: Administration, Oral; Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Leukopenia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin; Prednisolone; Thrombocytosis; Vincristine

1984
Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
    American journal of clinical oncology, 1982, Volume: 5, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Middle Aged; Podophyllotoxin; Thrombocytopenia

1982
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diarrhea; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Half-Life; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction; Thrombocytopenia

1994
[Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
    Zhonghua nei ke za zhi, 1994, Volume: 33, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cross-Over Studies; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins

1994
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia

1995
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7

    Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Thrombocytopenia

1995
Combination chemotherapy with cyclophosphamide, vincristine, cisplatin and etoposide (COPE) combined with radiotherapy for small cell lung cancer.
    The Korean journal of internal medicine, 1995, Volume: 10, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Combinations; Etoposide; Humans; Leukopenia; Life Tables; Lung Neoplasms; Middle Aged; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine

1995
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Logistic Models; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Proportional Hazards Models; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; United States; Vinblastine; Vincristine

1995
Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Esophagitis; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Leukopenia; Lung Neoplasms; Neoplasm Staging; Neutropenia; Paclitaxel; Radiotherapy; Remission Induction

1995
Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Nausea; Salvage Therapy; Vomiting

1995
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:6

    Topics: Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Salvage Therapy; Survival Analysis

1995
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.
    Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cohort Studies; Dose-Response Relationship, Drug; Etoposide; Female; Half-Life; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds

1995
[Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Proportional Hazards Models; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting

1995
[Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1994, Volume: 16, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cross-Over Studies; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins

1994
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Remission Induction; Survival Rate; Thrombocytopenia; Weight Loss

1994
[Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prognosis

1994
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Japanese journal of clinical oncology, 1994, Volume: 24, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil

1994
[Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:16

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Treatment Outcome

1994
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction; Thrombocytopenia

1994
[Phase I clinical study of 21-consecutive-day oral administration of etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:10

    Topics: Administration, Oral; Adult; Aged; Drug Tolerance; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms

1994
Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Treatment Outcome

1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia; Treatment Outcome

1994
CVM versus ACE in the treatment of small cell lung cancer.
    Oncology, 1993, Volume: 50 Suppl 2

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Infections; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Thrombocytopenia; Treatment Outcome; Vinblastine

1993
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomas.
    The Journal of infusional chemotherapy, 1995,Summer, Volume: 5, Issue:3

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Sarcoma; Stomatitis; Treatment Outcome

1995
An early phase II study of etoposide (VP-16) in advanced gastric cancer.
    Japanese journal of clinical oncology, 1996, Volume: 26, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Alopecia; Anemia; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Stomach Neoplasms

1996
Etoposide with/without G-CSF with busulfan and cyclophosphamide as conditioning for bone marrow transplantation. The BMT Team.
    American journal of hematology, 1996, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunologic Factors; Leukemia, Myeloid; Leukopenia; Male; Middle Aged; Premedication; Salvage Therapy

1996
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.
    American journal of clinical oncology, 1996, Volume: 19, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lung; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Remission Induction; Survival Rate; Thrombocytopenia

1996
Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamics.
    Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Linear Models; Male; Middle Aged; Recombinant Proteins

1996
The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
    Experimental hematology, 1996, Volume: 24, Issue:10

    Topics: Adolescent; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Glucocorticoids; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1996
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 1996, Volume: 63, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Cohort Studies; Endometrial Neoplasms; Etoposide; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Thrombocytopenia; Time Factors

1996
Pharmacodynamic modeling of prolonged administration of etoposide.
    Cancer chemotherapy and pharmacology, 1996, Volume: 39, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Catheterization, Central Venous; Etoposide; Female; Humans; Leukopenia; Male; Models, Biological

1996
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
    Journal of surgical oncology, 1997, Volume: 64, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Vomiting

1997
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
    Japanese journal of clinical oncology, 1997, Volume: 27, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Survival Analysis

1997
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia

1997
Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non-Hodgkin's lymphoma.
    American journal of clinical oncology, 1997, Volume: 20, Issue:3

    Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Recurrence; Remission Induction; Survival Analysis; Thrombocytopenia; Time Factors

1997
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    American journal of clinical oncology, 1997, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Clinical Trials, Phase II as Topic; Cochlea; Digestive System Neoplasms; Drug Administration Schedule; Drug Synergism; Esophageal Neoplasms; Etoposide; Evaluation Studies as Topic; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Remission Induction; Sepsis; Stomach Neoplasms; Thrombocytopenia; Vomiting

1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant; Infections; Infusions, Intravenous; Leukopenia; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome; Vincristine

1997
Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:12

    Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Thrombocytopenia

1997
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Incidence; Leukocyte Count; Leukopenia; Male; Mechlorethamine; Middle Aged; Platelet Count; Prednisone; Procarbazine; Prospective Studies; Recombinant Proteins; Treatment Outcome; Vinblastine; Vincristine

1998
CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial.
    American journal of clinical oncology, 1998, Volume: 21, Issue:3

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vincristine

1998
Does chemotherapy-induced leukopenia predict a response in small-cell lung cancer?
    Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Treatment Outcome; Vincristine

1998
Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:5

    Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Prognosis; Stomach Neoplasms; Survival Analysis

1998
The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Creatinine; Esophageal Neoplasms; Etoposide; Female; Hematologic Tests; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Sex Factors; Thrombocytopenia

1998
Limited sampling model for the area under the concentration versus time curve of irinotecan and its application to a multicentric phase II trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:7

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Metabolic Clearance Rate; Middle Aged; Nausea; Recombinant Proteins; Reproducibility of Results; Vomiting

1997
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Half-Life; Hemoglobins; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds; Thrombocytopenia

1995
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Cancer, 1998, Nov-15, Volume: 83, Issue:10

    Topics: Administration, Oral; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Mitotane; Prospective Studies; Thrombocytopenia; Treatment Outcome

1998
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13

    Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms

1998
Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:12

    Topics: Administration, Oral; Adult; Aged; Alopecia; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vomiting

1998
Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.
    Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Etoposide; Female; Humans; Interferon-gamma; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine

1999
Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Cancer, 1999, May-15, Volume: 85, Issue:10

    Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiotherapy; Survival Analysis; Treatment Outcome; Vomiting, Anticipatory

1999
Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051).
    Cancer, 1999, Oct-15, Volume: 86, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Prognosis; Radiotherapy Dosage; Remission Induction; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vinblastine

1999
Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study.
    Journal of experimental & clinical cancer research : CR, 1999, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bone Marrow; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; India; Leukocyte Count; Leukopenia; Lipid Peroxidation; Male; Mitoxantrone; Neoplasms; Pharmaceutical Preparations; Pilot Projects; Plant Extracts; Radiation Injuries; Radiotherapy

1999
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Bone Marrow Diseases; Chromatography, High Pressure Liquid; Cyclosporine; Drug Resistance, Neoplasm; Erythroid Precursor Cells; Etoposide; Female; Genes, MDR; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukocyte Count; Leukopenia; Male; Middle Aged

2000
A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer.
    American journal of clinical oncology, 2000, Volume: 23, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Esophagitis; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thrombocytopenia; Treatment Outcome

2000
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Blood Transfusion; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Count; Prednisone; Procarbazine; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine

2000
Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:7

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Neutropenia; Severity of Illness Index; Thrombocytopenia; Treatment Outcome

2001
Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy--a pilot study.
    Phytotherapy research : PTR, 2002, Volume: 16, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Echinacea; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukocyte Count; Leukopenia; Lymphocytes; Male; Middle Aged; Phytotherapy; Pilot Projects; Plant Extracts; Polysaccharides; Stomach Neoplasms; Treatment Outcome

2002
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Cancer treatment reports, 1979, Volume: 63, Issue:8

    Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide

1979
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
    Oncology, 1992, Volume: 49 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine

1992
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia

1992
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:12

    Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia

1992
Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.
    Acta oncologica (Stockholm, Sweden), 1992, Volume: 31, Issue:7

    Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Radiography; Time Factors; Treatment Outcome; Vincristine

1992
[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer].
    Bulletin du cancer, 1992, Volume: 79, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thrombocytopenia

1992
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Time Factors; Vincristine

1992
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Injections, Intravenous; Leukopenia; Middle Aged; Ovarian Neoplasms

1992
5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.
    Cancer, 1991, Sep-01, Volume: 68, Issue:5

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia

1991
Excessive toxicity of mitoxantrone combined with etoposide in advanced non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitoxantrone

1991
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:3

    Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Injections, Intraperitoneal; Leukemia P388; Leukopenia; Male; Mice; Middle Aged; Peritoneal Neoplasms; Podophyllotoxin; Remission Induction; Teniposide

1991
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Remission Induction; Survival Rate; United States; Vincristine

1990
Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Middle Aged; Pilot Projects; Platelet Count; Recombinant Proteins; Time Factors; Vincristine

1990
[A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Random Allocation; Remission Induction

1989
[Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:11

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Vincristine; Vindesine

1988
VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma.
    Cancer, 1985, Sep-01, Volume: 56, Issue:5

    Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Prognosis; Prospective Studies; Random Allocation

1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
    American journal of clinical oncology, 1985, Volume: 8, Issue:5

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting

1985

Other Studies

115 other study(ies) available for etoposide and Leukopenia

ArticleYear
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2018, Volume: 194, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cohort Studies; Dacarbazine; Etoposide; Female; Glioma; Humans; Ifosfamide; Leukopenia; Male; Neoplasm Grading; Prospective Studies; Temozolomide; Treatment Outcome; Vincristine

2018
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.
    Journal of cancer research and clinical oncology, 2018, Volume: 144, Issue:2

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoiesis; Humans; Leukopenia; Models, Biological; Neoplasms; Polyethylene Glycols; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Reproducibility of Results; Vincristine

2018
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
    Oncology, 2018, Volume: 94, Issue:4

    Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Female; Health Status; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia

2018
Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
    International journal of radiation oncology, biology, physics, 2018, 03-01, Volume: 100, Issue:3

    Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Organs at Risk; Paclitaxel; Probability; Radiation Dosage; Retrospective Studies; ROC Curve; Small Cell Lung Carcinoma; Thoracic Vertebrae

2018
Lamotrigine-associated hemophagocytic lymphohistiocytosis.
    Blood, 2019, 03-07, Volume: 133, Issue:10

    Topics: Biopsy; Bone Marrow; Dexamethasone; Drug Resistant Epilepsy; Etoposide; Ferritins; Humans; Interleukin-2 Receptor alpha Subunit; Lacosamide; Lamotrigine; Leukopenia; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Thrombocytopenia; Transaminases

2019
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
    American journal of clinical oncology, 2017, Volume: 40, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia

2017
[Efficiency and adverse effects of the effective therapy applying etoposide + cisplatin and its subsequent maintenance therapy with different durations in patients with small cell lung cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, Jun-23, Volume: 38, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Humans; Hypokinesia; Leukopenia; Lung Neoplasms; Nausea; Neutropenia; Remission Induction; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia; Vomiting

2016
[Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2008, Volume: 27, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, High-Energy; Remission Induction; Small Cell Lung Carcinoma; Survival Rate

2008
[A case of small cell lung cancer with dermatomyositis that deteriorated with leukocytopenia due to chemotherapy].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dermatomyositis; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Middle Aged; Paraneoplastic Syndromes; Small Cell Lung Carcinoma

2008
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:11

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemoradiotherapy; Cognition Disorders; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Radiotherapy; Retrospective Studies; Survivors; Young Adult

2011
Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Neutropenia; Retrospective Studies; Thymus Neoplasms; Treatment Outcome; Vincristine

2011
Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Male; Retrospective Studies; Sarcoma, Kaposi; Thrombocytopenia; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine

2012
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult

2012
Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia/lymphoma with skin involvement.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fatigue; Female; Humans; Kaplan-Meier Estimate; Leukemia-Lymphoma, Adult T-Cell; Leukopenia; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prednisolone; Proportional Hazards Models; Retrospective Studies; Skin; Ultraviolet Therapy; Vomiting

2013
Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Vinblastine

2012
[Clinical pathway based on evidence-based medicine (EBM) for chemotherapy for lung cancer].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2004, Volume: 124, Issue:12

    Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Critical Pathways; Etoposide; Evidence-Based Medicine; Female; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vomiting

2004
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Annals of hematology, 2005, Volume: 84, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Pneumonia; Prednisone; Procarbazine; Retrospective Studies; Sepsis; Vincristine

2005
[Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Zhonghua fu chan ke za zhi, 2005, Volume: 40, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Trophoblastic Tumor, Placental Site; Uterine Neoplasms

2005
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-15, Volume: 11, Issue:10

    Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia

2005
[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Vinblastine

2005
Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia.
    British journal of haematology, 2006, Volume: 132, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Leukopenia; Lymphoma, Non-Hodgkin; Male; Mathematics; Middle Aged; Models, Biological; Prednisone; Risk Factors; Severity of Illness Index; Vincristine

2006
[Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Pericardiocentesis; Survival Rate

2006
Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
    Japanese journal of clinical oncology, 2006, Volume: 36, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Prognosis; Recombinant Proteins; Serotonin Antagonists; Survival Rate; Testicular Neoplasms; Thrombocytopenia

2006
Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
    Hinyokika kiyo. Acta urologica Japonica, 2007, Volume: 53, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Estramustine; Etoposide; Humans; Leukopenia; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Thrombocytopenia

2007
Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 57, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Time Factors; Topotecan

2007
[Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Zhonghua fu chan ke za zhi, 2007, Volume: 42, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vomiting; Young Adult

2007
Adriamycin, cyclophosphamide, and etoposide (VP-16-213) in extensive-stage small cell lung cancer.
    American journal of clinical oncology, 1984, Volume: 7, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis

1984
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
    Cancer, 1984, Apr-01, Volume: 53, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia; Time Factors

1984
[Effects of oral etoposide in small cell carcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:6

    Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Nausea; Podophyllotoxin; Thrombocytopenia

1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors.
    American journal of clinical oncology, 1984, Volume: 7, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fever; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal

1984
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
    Annals of internal medicine, 1983, Volume: 98, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leucovorin; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine

1983
VP-16 and adriamycin in patients with advanced breast cancer.
    American journal of clinical oncology, 1982, Volume: 5, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prednisone; Thrombocytopenia; Vincristine; Vomiting

1982
VP16-213 as a single agent in advanced testicular tumors.
    European journal of cancer, 1980, Volume: 16, Issue:9

    Topics: Drug Evaluation; Dysgerminoma; Etoposide; Humans; Leukopenia; Male; Podophyllotoxin; Teratoma; Testicular Neoplasms; Thrombocytopenia

1980
A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.
    European journal of cancer, 1981, Volume: 17, Issue:2

    Topics: Adult; Drug Evaluation; Etoposide; Humans; Leukopenia; Male; Middle Aged; Podophyllotoxin; Teratoma; Testicular Neoplasms; Time Factors

1981
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Neoplasm Staging; Neutropenia; Sarcoma; Thrombocytopenia; Time Factors

1995
[Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1993, Volume: 84, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Testicular Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine

1993
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Vincristine

1993
Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Thrombocytopenia

1995
A population model for the leukopenic effect of etoposide.
    Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:3

    Topics: Adult; Aged; Bias; Etoposide; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Models, Biological; Models, Statistical; Reproducibility of Results

1995
Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Regression Analysis

1995
[Therapeutic effect of carboplatin and etoposide combinative therapy on 123 lung cancer cases].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1994, Volume: 16, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Middle Aged; T-Lymphocyte Subsets

1994
Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
    Bone marrow transplantation, 1994, Volume: 13, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Blood Component Transfusion; Busulfan; Combined Modality Therapy; Etoposide; Female; Flow Cytometry; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Lymphocyte Subsets; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1994
Influence of cytostatic agents on the pulmonary defence of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone.
    The Journal of infection, 1994, Volume: 29, Issue:1

    Topics: Animals; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Ceftriaxone; Cyclophosphamide; Disease Models, Animal; Etoposide; Granulocytes; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Leukopenia; Lung Diseases; Macrophages, Alveolar; Male; Mice; Phagocytosis; Specific Pathogen-Free Organisms

1994
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement.
    American journal of hematology, 1994, Volume: 47, Issue:4

    Topics: Albinism; Central Nervous System Diseases; Child; Etoposide; Female; Fever; Humans; Leukopenia; Methylprednisolone; Movement Disorders; Syndrome; Thrombocytopenia

1994
Infections in patients treated with high-dose chemotherapy for germ cell tumours.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:16

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Cisplatin; Etoposide; Germinoma; Herpes Simplex; Humans; Immunocompromised Host; Infections; Leukopenia; Male

1993
21-day schedule oral etoposide in children--a feasibility study.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:16

    Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Leukemia; Leukopenia; Male; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Treatment Outcome

1993
Predictive performance of a pharmacodynamic model for oral etoposide.
    Cancer research, 1994, Apr-15, Volume: 54, Issue:8

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged; Models, Biological; Prospective Studies

1994
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Feasibility Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Time Factors

1993
Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:6

    Topics: Administration, Oral; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged

1993
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia

1996
Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer.
    Japanese journal of cancer research : Gann, 1996, Volume: 87, Issue:8

    Topics: Administration, Oral; Drug Monitoring; Etoposide; Humans; Leukopenia; Lung Neoplasms

1996
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil

1996
Granulocyte-colony stimulating factor fails to prevent leucopenia caused by CEMP in elderly patients with aggressive lymphoma.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1996, Volume: 86, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednisone; Recombinant Proteins

1996
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hepatitis B; Hepatitis C; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Taiwan; Thrombocytopenia; Virus Diseases

1998
Indirect-response model for the time course of leukopenia with anticancer drugs.
    Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Mathematical Computing; Middle Aged; Models, Theoretical; Paclitaxel; Time Factors

1998
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
    Cancer, 1999, Jan-15, Volume: 85, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Leukemia, Myeloid; Leukopenia; Liver; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Survival Rate; Treatment Outcome

1999
[Colony stimulating factors in polychemotherapy of testicular tumors. A comparison between G-CSF and GM-CSF].
    Der Urologe. Ausg. A, 1999, Volume: 38, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Leukopenia; Male; Neoplasms, Germ Cell and Embryonal; Recombinant Proteins; Testicular Neoplasms; Treatment Outcome

1999
Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis.
    Arthritis and rheumatism, 2000, Volume: 43, Issue:10

    Topics: Animals; Arthritis, Infectious; Down-Regulation; Etoposide; Female; Interleukin-6; Leukopenia; Lymphocyte Activation; Macrophages; Male; Mice; Monocytes; Staphylococcal Infections; Tumor Necrosis Factor-alpha

2000
Carcinoma of unknown primary site.
    Cancer, 2000, Dec-15, Volume: 89, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting

2000
Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis.
    Medical and pediatric oncology, 2002, Volume: 38, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Child; Daclizumab; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulin G; Immunosuppressive Agents; Leukopenia; Male

2002
Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside).
    Cancer, 1977, Volume: 40, Issue:2

    Topics: Administration, Oral; Aged; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Solutions

1977
[Experiences with VP-16 in combination with cyclophosphamide or adriamycin in the anaplastic, predominantly small cell bronchogenic carcinoma].
    Schweizerische medizinische Wochenschrift, 1979, Jun-02, Volume: 109, Issue:22

    Topics: Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Leukopenia; Patient Isolation; Podophyllotoxin

1979
Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Leukopenia; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia

1992
Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy.
    International journal of hematology, 1992, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Macrophage Colony-Stimulating Factor; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Predictive Value of Tests; Prednisone; Remission Induction; Vindesine

1992
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.
    Tumori, 1991, Dec-31, Volume: 77, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Remission Induction; Salvage Therapy; Vincristine

1991
Pharmacokinetics of an etoposide infused over three days: concomitant infusion with cisplatin.
    Japanese journal of clinical oncology, 1991, Volume: 21, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis

1991
Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancer.
    Cancer, 1990, Jun-15, Volume: 65, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Colony-Stimulating Factors; Drug Evaluation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Remission Induction; Survival Rate

1990
Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Humans; L-Lactate Dehydrogenase; Leukopenia; Male; Middle Aged; Thrombocytopenia; Vinblastine

1991
Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Diarrhea; Drug Evaluation; Etoposide; Female; Floxuridine; Gastrointestinal Neoplasms; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Risk Factors; Stomatitis; Thrombocytopenia

1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation.
    American journal of clinical oncology, 1991, Volume: 14, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Remission Induction; Survival Rate; Time Factors

1991
[The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6

    Topics: Adenocarcinoma; Administration, Oral; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Humans; Infusions, Intravenous; Kidney; Leukopenia; Lung Neoplasms

1991
Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study.
    Cancer chemotherapy and pharmacology, 1991, Volume: 27, Issue:5

    Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Pilot Projects; Thrombocytopenia; Vomiting

1991
Chronic daily administration of oral etoposide in refractory lymphoma.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Thrombocytopenia

1990
Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:6

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Erythromycin; Etoposide; Leukocyte Count; Leukopenia; Male; Mice; Roxithromycin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus

1990
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
    Investigational new drugs, 1990, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Mesna; Middle Aged; Nausea; Ovarian Neoplasms; Sarcoma, Ewing; Testicular Neoplasms; Vomiting

1990
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Remission Induction; Thrombocytopenia

1990
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Thrombocytopenia

1990
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
    Cancer investigation, 1990, Volume: 8, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction

1990
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma.
    American journal of clinical oncology, 1990, Volume: 13, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Drug Evaluation; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia

1990
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer.
    Medical and pediatric oncology, 1990, Volume: 18, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Inflammation; Leukocyte Count; Leukopenia; Mucous Membrane; Platelet Count; Remission Induction; Thrombocytopenia

1990
High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iodohippuric Acid; Kidney; Leukopenia; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms

1986
Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Pilot Projects

1988
[Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Uracil

1989
Evaluation of management of gestational trophoblastic tumor in National Taiwan University Hospital.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Leucovorin; Leukopenia; Liver; Mercaptopurine; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Remission Induction; Risk Factors; Taiwan; Trophoblastic Neoplasms; Uterine Neoplasms

1989
[Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Pilot Projects; Remission Induction; Thrombocytopenia; Vincristine

1989
[Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:6

    Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Pilot Projects; Remission Induction; Thrombocytopenia

1989
[Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Thrombocytopenia; Vomiting

1989
Phase II study with etoposide in previously untreated advanced breast cancer.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4

    Topics: Adult; Aged; Alopecia; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Tolerance; Etoposide; Female; Humans; Injections, Intravenous; Leukopenia; Middle Aged; Pilot Projects; Platelet Count; Remission Induction

1989
Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:6

    Topics: Animals; Cloxacillin; Cyclophosphamide; Drug Interactions; Erythromycin; Etoposide; Leukocyte Count; Leukopenia; Mice; Staphylococcal Infections

1989
[Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms

1989
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prognosis; Time Factors

1988
Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Etoposide; Humans; Leukopenia; Male; Mouth Mucosa; Neoplasms, Germ Cell and Embryonal; Stomatitis; Testicular Neoplasms; Thrombocytopenia

1988
Etoposide and split-dose cisplatin in small-cell lung cancer.
    American journal of clinical oncology, 1988, Volume: 11, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged

1988
Oral etoposide preceding cisplatin in advanced non small cell lung cancer (NSCLC). A phase II study.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prognosis

1988
VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.
    British journal of cancer, 1988, Volume: 58, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds

1988
Etoposide admixed with cisplatin. Phase I clinical investigation of 72-hour infusion.
    Cancer, 1989, Mar-01, Volume: 63, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Drug Combinations; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Remission Induction

1989
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Digestive System; Doxorubicin; Etoposide; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Vincristine

1985
Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
    Cancer treatment reports, 1985, Volume: 69, Issue:1

    Topics: Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Multi-Institutional Systems; Nausea; Podophyllotoxin; Vomiting

1985
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Thrombocytopenia; Vincristine

1985
Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer.
    Cancer, 1985, Sep-15, Volume: 56, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged

1985
[A phase II study of NK171 (etoposide)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin

1985
Hepatic metastases in gestational trophoblastic disease.
    Obstetrics and gynecology, 1986, Volume: 67, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms

1986
Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: tumor response and long term survival.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia

1986
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Fever; Humans; Infections; Leukopenia; Lung Neoplasms; Middle Aged; Thrombocytopenia

1987
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.
    Cancer, 1988, Jul-01, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Evaluation Studies as Topic; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Mesna; Mesonephroma; Nausea; Sepsis; Teratoma; Testicular Neoplasms

1988
Cisplatin and etoposide in chemotherapy-refractory advanced breast cancer.
    Tumori, 1988, Apr-30, Volume: 74, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Vomiting

1988
Effect of monocytopenia on trauma-induced atherosclerotic lesions in the rabbit ear artery.
    Experimental and molecular pathology, 1988, Volume: 49, Issue:1

    Topics: Animals; Arteries; Arteriosclerosis; Disease Models, Animal; Etoposide; Female; Hematocrit; Leukocyte Count; Leukopenia; Monocytes; Prednisolone; Rabbits

1988
Etoposide for epidemic Kaposi's sarcoma: a phase II study.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:6

    Topics: Adult; Drug Evaluation; Etoposide; Humans; Leukopenia; Sarcoma, Kaposi; Thrombocytopenia

1988
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.
    Cancer treatment reports, 1987, Volume: 71, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hodgkin Disease; Humans; Leukopenia; Lomustine; Male; Methotrexate; Middle Aged

1987
EVA treatment for recurrent or unresponsive Hodgkin's disease.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Vincristine

1986
[A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:2

    Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kinetics; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Thrombocytopenia

1986
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine

1986
[Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:7

    Topics: Administration, Oral; Adult; Aged; Capsules; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia

1985
Role of granulocytes and monocytes in the prevention and therapy of experimental Staphylococcus epidermidis endocarditis in rabbits.
    The Journal of infection, 1985, Volume: 11, Issue:1

    Topics: Animals; Blood Bactericidal Activity; Cloxacillin; Endocarditis; Endocarditis, Bacterial; Etoposide; Granulocytes; Leukocyte Count; Leukopenia; Male; Mechlorethamine; Monocytes; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis

1985
Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer.
    American journal of clinical oncology, 1985, Volume: 8, Issue:5

    Topics: Alopecia; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Leukopenia; Lymphatic Metastasis; Podophyllotoxin

1985